Novo Kidney Trial Finds Ozempic Cuts Cardiac Deaths in Diabetics Novo Kidney Trial Finds Ozempic Cuts Cardiac Deaths in Diabetics
Novo Nordisk ' s widely used diabetes drug Ozempic delayed progression of chronic kidney disease in diabetes patients, a large late-stage study found, cutting the risk of...Reuters Health Information (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - March 5, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news
Mayo Clinic Minute: Why Black Americans are at higher risk of chronic kidney disease
Chronic kidney disease is a condition where your kidneys lose their ability to filter waste and fluid from your blood. This can lead to serious health problems such as heart disease, stroke and kidney failure.The Black community faces a higher risk of chronic kidney disease. This can be due to genetics, higher rates of hypertension and diabetes, and socioeconomic issues such as access to healthcare and structural racism. Dr. Ivan Porter II, a Mayo Clinic nephrologist, says these factors create a… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - March 5, 2024 Category: Databases & Libraries Source Type: news
Gout increases the risk of multiple diseases
A study shows that gout not only increases the risk of a broad range of cardiovascular diseases it also leads to a higher prevalence of other health conditions, including chronic kidney disease, high blood pressure and an increased Body Mass Index (BMI). Researchers from the Universities of Oxford, Glasgow, and KU Leuven in Belgium found... Read moreThe post Gout increases the risk of multiple diseases appeared first on Nursing in Practice. (Source: Nursing in Practice)
Source: Nursing in Practice - February 22, 2024 Category: Nursing Authors: Carolyn Scott Tags: Cardiology Older people care gout Source Type: news
Drug Trials Snapshots: JESDUVROQ
JESDUVROQ is a hypoxia-inducible factor prolyl hydroxylase (HIF PH) inhibitor that treats anemia due to chronic kidney disease (CKD) in adults who have been receiving dialysis for at least four months. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - February 22, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Risk of fall in patients with chronic kidney disease: results from the China Health and Retirement Longitudinal Study (CHARLS) - Lin P, Wan B, Zhong J, Wang M, Tang F, Wang L, Guo J, Ye Y, Liu X, Peng L, Deng L.
BACKGROUND: Chronic kidney disease (CKD), often coexisting with various systemic disorders, may increase the risk of falls. Our study aimed to assess the prevalence and risk of falls among patients with CKD in China. METHODS: We included patients w... (Source: SafetyLit)
Source: SafetyLit - February 19, 2024 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news
Boehringer's Jardiance now gets CDSCO nod for chronic kidney disease
The Central Drugs Standard Control Organisation of India has approved Jardiance, a 10mg dosage form of empagliflozin, for the treatment of chronic kidney disease (CKD). This approval allows nephrologists and cardiologists to use Jardiance for eligible CKD patients, reducing hospitalizations and addressing unmet medical needs. (Source: The Economic Times)
Source: The Economic Times - February 14, 2024 Category: Consumer Health News Source Type: news
'Miracle' weight-loss drugs could halt kidney disease too
People with chronic kidney disease could become the latest patients offered Weight-loss jabs such as Ozempic and Wegovy on the NHS, as the health service tries to combat the growing problem. (Source: the Mail online | Health)
Source: the Mail online | Health - February 11, 2024 Category: Consumer Health News Source Type: news
Exercise reduces risk of kidney disease in patients with type 2 diabetes
Regular bouts of moderate to vigorous activity can protect patients with type 2 diabetes from developing kidney disease, a research study has found. Overweight and obese people with type 2 diabetes who undertook moderate to vigorous physical activity every week were significantly less likely to progress to chronic kidney disease than those who undertook minimal... Read moreThe post Exercise reduces risk of kidney disease in patients with type 2 diabetes appeared first on Nursing in Practice. (Source: Nursing in Practice)
Source: Nursing in Practice - February 8, 2024 Category: Nursing Authors: Carolyn Scott Tags: Diabetes chronic kidney disease Exercise Source Type: news
Insulin Resistance Doesn't Affect Finerenone's Efficacy Insulin Resistance Doesn't Affect Finerenone's Efficacy
Insulin resistance may increase the risk for cardiovascular outcomes but not kidney outcomes in patients with type 2 diabetes and chronic kidney disease.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - January 29, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news
Risk for CKD, CVD Lower for Adults With Evidence of Type 2 Diabetes Remission
FRIDAY, Jan. 26, 2024 -- Individuals with evidence of remission of type 2 diabetes have a considerably reduced risk for chronic kidney disease (CKD) and cardiovascular disease (CVD), according to a study published online Jan. 18 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 26, 2024 Category: Pharmaceuticals Source Type: news
T2D Remission Buffers; Another Sotagliflozin Trial; More Gender-Affirming Care Bans?
(MedPage Today) -- People with any evidence of type 2 diabetes remission with diet and lifestyle changes had a 40% lower rate of cardiovascular disease and a 33% lower rate of chronic kidney disease versus those without remission, according to... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - January 23, 2024 Category: Endocrinology Source Type: news
FDA Adds Warning to Osteoporosis Drug for Hypocalcemia Risk FDA Adds Warning to Osteoporosis Drug for Hypocalcemia Risk
Based on a completed data review, the agency concluded that denosumab increases the risk for severe hypocalcemia in patients with chronic kidney disease.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - January 19, 2024 Category: Internal Medicine Tags: Nephrology Source Type: news
FDA Slaps Boxed Warning on Osteoporosis Drug
(MedPage Today) -- The FDA added a boxed warning to the label of the osteoporosis drug denosumab (Prolia) over the risk of severe hypocalcemia in patients with advanced chronic kidney disease (CKD), the agency announced Friday.
After a review... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - January 19, 2024 Category: Endocrinology Source Type: news
Prolia (denosumab): Drug Safety Communication - FDA Adds Boxed Warning for Increased Risk of Severe Hypocalcemia in Patients with Advanced Chronic Kidney Disease
FDA Adds Boxed Warning for Increased Risk of Severe Hypocalcemia in Patients with Advanced Chronic Kidney Disease Taking Osteoporosis Medicine Prolia (Denosumab): FDA Safety Communication. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - January 19, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Why Is Kidney Disease So Often Missed? Why Is Kidney Disease So Often Missed?
Fifteen percent of Americans have chronic kidney disease, so why do only 10% know about it? Primary care clinicians can and should be doing more to identify patients.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - January 17, 2024 Category: Drugs & Pharmacology Tags: Internal Medicine Source Type: news
